Report Overview

The South Korean cardiovascular drugs market size stood at around USD 3 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In the past decade cardiovascular diseases have shown a continuous increase in Korea and has become the second most common cause of mortality. This increase in the number of cases is the primary source of contribution to market growth. The prevalence of detrimental lifestyles among people like change in food habits, sedentary lifestyle, drinking and smoking has upsurge the risk of cardiovascular diseases. Heavy consumption of alcohol is linked to increased cardiovascular mortality. Sedentary lifestyles are associated with metabolic dysfunctions, such as elevated plasma triglycerides and high-density lipoprotein (HDL) cholesterol and reduced insulin sensitivity.



Market Drivers

Korea which is currently an aged society is on the verge of becoming a superaged society in a few years. With increasing age, the burden of cardiovascular diseases increases.

Also, the increasing prevalence of cardiovascular risk factors, such as obesity, hypertension, diabetes mellitus, and dyslipidaemia, may be linked to increased population-level cardiovascular risk. In 2018, the prevalence of obesity in Korea was 35.7% according to the Obesity Fact Sheet 2019, based on National Health Insurance Corporation medical check-up data. According to the Korean Hypertension Fact Sheet produced by the Korean Society of Hypertension the prevalence of hypertension in the total population of Korea in 2018 was 28.3%. While the prevalence of dyslipidaemia in 2018 was 40.5% according to the Dyslipidaemia Fact Sheet published by the Korean Society of Lipid and Atherosclerosis.

Deskbound lifestyle, surplus consumption of alcohol, stress, harmful eating habits, smoking are all factors liable for the rise within the number of cardiovascular disorders among young people.